Coronavirus Outbreak: All the Secrets Revealed About the Covid-19 Pandemic. A complete Rational Guide of its Evolution, Expansion, Symptoms and First Defense

5. Monitor and Manage Ill and Exposed Healthcare Personnel
Workers Movement and control decisions should be taken in coordination
with public health authorities for HCP with access to Covid-19. Health care
facilities and entities will adopt HCP sick leave policies that are non-punitive,
flexible, and compatible with recommendations for public health.
6. Train and Educate Healthcare Personnel
Provide HCP with job-or task-specific training and training to prevent
infectious agent transmission, including refresher training. HCP must be
medically cleaned, trained and checked for the use of respiratory protective
devices (e.g., N95 filtering face piece respirators) or medically cleaned and
trained to use an alternative respiratory protective device (e.g., Powered Air-
Purifying Respirator, PAPR) if respirators are needed. OSHA has a variety of
videos external symbol for the respiratory instruction.
Ensure that HCP is prepared, qualified and used properly before taking care
of a patient, including consideration for proper use of PPE and avoidance of
clothing, skin and environment contamination during the removal process.
7. Implement Environmental Infection Control
All non-dedicated, non-disposable medical equipment used for patient care
should be washed and disinfected as per the guidelines and facilities policies
of the manufacturer.
Ensure the processes for the environmental cleaning and disinfection are
regularly and correctly followed. Routine cleaning and disinfection
procedures (e.g., use of cleaners and water on pre-clean surfaces before
applying an EPA-registered, hospital-grade disinfectant to regularly touched
surfaces or items for acceptable contact times as indicated on the product
label) are appropriate for Covid-19 in healthcare environments, including
those patient care areas where aerosol-generating procedures are used. Goods
that are believed to have emerging viral pathogens licensed by EPA are
recommended for use against Covid-19.